Top 5 Stocks ›
→ Elon has entered the MarkBeat conversation (From Altimetry) (Ad) Free QNTM Stock Alerts

Quantum Biopharma (QNTM) SEC Filings & 10K Form

Quantum Biopharma logo
$12.25 +0.93 (+8.22%)
Closing price 04:00 PM Eastern
Extended Trading
$11.75 -0.50 (-4.08%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Quantum Biopharma SEC Filings

Export to Excel
DateFilerForm TypeView
02/06/2025
6:30 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/04/2025
6:30 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/21/2025
3:00 PM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/17/2025
6:31 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/14/2025
7:30 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/07/2025
7:32 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/20/2024
8:16 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/25/2024
6:22 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/29/2024
6:31 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/22/2024
6:54 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/21/2024
7:50 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/07/2024
6:32 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2024
7:09 PM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
6:27 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/09/2024
6:39 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/06/2024
8:22 PM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/30/2024
8:46 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/26/2024
7:20 PM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 424B5
08/26/2024
5:18 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/19/2024
4:18 PM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K/A
08/15/2024
7:15 PM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2024
6:07 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2024
5:13 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2024
5:15 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K/A
08/12/2024
5:03 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/09/2024
6:30 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/29/2024
8:04 PM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/08/2024
4:16 PM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/08/2024
2:20 PM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/28/2024
6:49 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2024
6:34 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/13/2024
6:31 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/04/2024
7:28 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/31/2024
6:30 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2024
7:15 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/24/2024
3:51 PM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/16/2024
7:01 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2024
5:02 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2024
7:31 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2024
7:33 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2024
6:49 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
5-Second Trump Clip will Give You Chills (Ad)

President Trump's prediction is about to become a reality... Opening a rare window of opportunity for you to accelerate your retirement during the first 100 days of his administration.

Click here now to get the details because you must act before January 20th.
04/22/2024
7:01 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/17/2024
7:01 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2024
7:03 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/09/2024
3:57 PM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/01/2024
8:22 PM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/27/2024
7:01 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/11/2024
7:00 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/05/2024
7:02 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/28/2024
7:00 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/26/2024
7:04 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
5:01 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
5:05 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:QNTM) was last updated on 2/10/2025 by MarketBeat.com Staff
From Our Partners
Grab This Altcoin Before Trump's Crypto Announcement
Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...
Crypto 101 Media | Sponsored
A deadly mistake in my prediction…
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
5-Second Trump Clip will Give You Chills
President Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...
InvestorPlace | Sponsored
Elon’s ‘Agents’ Strike
He might be the richest man on the planet – but Elon Musk just landed himself a new job... In a move that c...
Altimetry | Sponsored
Bill O’Reilly: “the best-prepared president in history.”
"We're going to bring back the American Dream... bigger, better, bolder, richer, safer, and stronger than ever...
The Oxford Club | Sponsored
Is Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...
Paradigm Press | Sponsored